|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-02 | Enveric Biosciences Initiates IND-Enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003 | CI |
| 06-02 | Enveric Biosciences Begins Genotoxicity Testing for EB-003 | MT |
| Market Cap | 5.45M 4.77M 4.4M 4.08M 7.75M 520M 7.85M 52.62M 20.48M 255M 20.46M 20.01M 885M | P/E 2024 |
-0.28x | P/E 2025 | -0.1x |
|---|---|---|---|---|---|
| Enterprise Value | 772K 676K 622K 578K 1.1M 73.61M 1.11M 7.45M 2.9M 36.13M 2.9M 2.83M 125M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -9.57M -8.39M -7.72M -7.17M -13.61M -913M -13.8M -92.46M -35.98M -448M -35.96M -35.17M -1.55B | -8.77M -7.68M -7.08M -6.57M -12.47M -837M -12.64M -84.7M -32.96M -411M -32.94M -32.22M -1.42B |
| Net Debt | -2.24M -1.96M -1.81M -1.68M -3.19M -214M -3.23M -21.64M -8.42M -105M -8.42M -8.23M -364M | -4.68M -4.1M -3.77M -3.5M -6.65M -446M -6.74M -45.17M -17.58M -219M -17.57M -17.18M -759M |
Employees
-
Sector
-
Select your edition
All financial news and data tailored to specific country editions
















